146
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Autologous transplant of follicular lymphoma in the era of rituximab

&
Pages 967-974 | Received 30 Dec 2009, Accepted 19 Mar 2010, Published online: 05 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho & Mathias Witzens-Harig. (2012) The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leukemia & Lymphoma 53:3, pages 386-393.
Read now

Articles from other publishers (8)

N. L. Berinstein, S. Bhella, N. M. Pennell, M. C. Cheung, K. R. Imrie, D. E. Spaner, V. Milliken, L. Zhang, K. Hewitt, A. Boudreau, M. D. Reis, A. Chesney, D. Good, Z. Ghorab, L. K. Hicks, E. Piliotis & R. Buckstein. (2015) Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab. Annals of Hematology 94:5, pages 813-823.
Crossref
Kai Hübel, Javier de la Rubia, Nabih Azar & Paolo Corradini. (2015) Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. European Journal of Haematology 94:1, pages 12-22.
Crossref
Natthapol Songdej & Eric S. Winer. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 247 266 .
Douglas A. Stewart, Qiuli Duan, Linda Carlson, James A. Russell, Nizar J. Bahlis, Peter Duggan, Wanda Hasegawa & Michael Voralia. (2011) A Prospective Phase II Study of RICE Re-Induction, Then High-Dose Fludarabine and Busulfan, Followed by Autologous or Allogeneic Blood Stem Cell Transplantation for Indolent B-Cell Lymphoma. ClinicalTrials.gov ID: NCT00144092. Clinical Lymphoma Myeloma and Leukemia 11:6, pages 475-482.
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:5, pages 537-546.
Crossref
Vit Prochazka, Tomas Papajik, Marie Jarosova & Karel Indrak. (2011) PROGNOSTIC FACTORS IN FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: HOW TO IDENTIFY A HIGH-RISK PATIENT?. Biomedical Papers 155:2, pages 99-108.
Crossref
P. Dreger. (2011) III. Role of allotransplantation for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Annals of Oncology 22, pages iv36-iv39.
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:2, pages 227-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.